PharmaCyte Biotech/ US71715X1046 /
| 4/9/2021 9:53:24 PM | Chg. -0.0002 | Volume | Bid- | Ask- | High | Low |
|---|---|---|---|---|---|---|
| 0.0179USD | -1.10% | 1.79 mill. Turnover: 32,168.5003 |
-Bid Size: - | -Ask Size: - | 0.0189 | 0.0174 |
GlobeNewswire
8/3/2020
PharmaCyte Biotech Ready to Submit Investigational New Drug Application to FDA for Clinical Trial in...
GlobeNewswire
6/29/2020
PharmaCyte Biotech’s COVID-19 Test Offers “Pool Testing” Dr. Fauci and White House Coronavirus Task ...
GlobeNewswire
4/20/2020
Developer of PharmaCyte Biotech’s COVID-19 Test Explains Why His Test Is So Highly Sensitive, Path t...
GlobeNewswire
4/13/2020
PharmaCyte Biotech to Offer COVID-19 Testing While Creating Revenue Stream for Pancreatic Cancer Pro...
GlobeNewswire
3/26/2020
PharmaCyte Biotech CEO Discusses Navigating Testing and IND Submission During COVID-19 Pandemic
Newsfile Corp
2/11/2020
Will PharmaCyte Biotech's Cell-in-a-Box(R) Technology Be The Game Changer To Effectively Treating Pa...
Newsfile Corp
2/6/2020
PharmaCyte Biotech Exploits Potential Of Its Cell-in-a-Box(R) Technology; Targets Billion Dollar Can...
GlobeNewswire
2/4/2020
PharmaCyte Biotech Will Have All the Protection It Needs for Pancreatic Cancer Treatment Upon Market...
GlobeNewswire
1/27/2020
PharmaCyte Biotech’s Pancreatic Cancer Therapy Passes Critical FDA-Required Tests as Countdown to IN...
GlobeNewswire
1/14/2020
PharmaCyte Biotech Addressing Unmet Need in Patients with LAPC as Pancreatic Cancer 5-Year Survival ...
GlobeNewswire
12/11/2019
PharmaCyte Biotech Finalizes Pancreatic Cancer Treatment for U.S. FDA Approval to Begin Clinical Tri...
GlobeNewswire
11/12/2019
PharmaCyte Biotech’s “Release Testing” Last Critical Event Before Submission of Investigational New ...
GlobeNewswire
10/28/2019
PharmaCyte Biotech to Change Future of Treating Diseases with Validation of Encapsulation Technology...
GlobeNewswire
10/16/2019
PharmaCyte Biotech Closer to Submitting IND with Successful Completion of Clinical Trial Product
GlobeNewswire
9/23/2019
PharmaCyte Biotech's Pancreatic Cancer Therapy Production in Final Days of Key Manufacturing Run
GlobeNewswire
6/27/2019
Qrons Appoints Veteran U.S. Based Biotech Executive Dr. John N. Bonfiglio to Lead IND and Capital Ma...
GlobeNewswire
1/23/2019
World-Renowned Oncologist Bullish on Potential of PharmaCyte’s Technology, Clinical Trial in Pancrea...
GlobeNewswire
9/21/2018
Global Pancreatic Cancer Therapy Market Analysis and Forecasts 2017-2025 - Increase in Number of The...
GlobeNewswire
6/6/2018
PharmaCyte’s Clinical Trial in Pancreatic Cancer Serves as Proving Ground for Its One of a Kind Cell...